Robotic gait rehabilitation and substitution devices in neurological disorders: where are we now?

被引:0
|
作者
Rocco Salvatore Calabrò
Alberto Cacciola
Francesco Bertè
Alfredo Manuli
Antonino Leo
Alessia Bramanti
Antonino Naro
Demetrio Milardi
Placido Bramanti
机构
[1] IRCCS Centro Neurolesi “Bonino Pulejo”,Department of Biomedical Sciences and Morphological and Functional Images
[2] University of Messina,undefined
来源
Neurological Sciences | 2016年 / 37卷
关键词
Lokomat; Robotic rehabilitation; Severe acquired brain injury; Spinal cord injury; Stroke;
D O I
暂无
中图分类号
学科分类号
摘要
Gait abnormalities following neurological disorders are often disabling, negatively affecting patients’ quality of life. Therefore, regaining of walking is considered one of the primary objectives of the rehabilitation process. To overcome problems related to conventional physical therapy, in the last years there has been an intense technological development of robotic devices, and robotic rehabilitation has proved to play a major role in improving one’s ability to walk. The robotic rehabilitation systems can be classified into stationary and overground walking systems, and several studies have demonstrated their usefulness in patients after severe acquired brain injury, spinal cord injury and other neurological diseases, including Parkinson’s disease, multiple sclerosis and cerebral palsy. In this review, we want to highlight which are the most widely used devices today for gait neurological rehabilitation, focusing on their functioning, effectiveness and challenges. Novel and promising rehabilitation tools, including the use of virtual reality, are also discussed.
引用
收藏
页码:503 / 514
页数:11
相关论文
共 50 条
  • [41] Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
    Misiak, Blazej
    Frydecka, Dorota
    Stanczykiewicz, Bartlomiej
    Samochowiec, Jerzy
    [J]. FRONTIERS IN PSYCHIATRY, 2019, 10
  • [42] Reusing single-use medical devices, where are we standing now?
    Naves, L. B.
    Abreu, M. J.
    [J]. OCCUPATIONAL SAFETY AND HYGIENE VI, 2018, : 541 - 545
  • [43] Early intervention in bipolar disorders: Where we are now and need to go next
    Duffy, Anne
    [J]. BIPOLAR DISORDERS, 2018, 20 (05) : 490 - 491
  • [44] Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
    Malcova, Hana
    Milota, Tomas
    Strizova, Zuzana
    Cebecauerova, Dita
    Striz, Ilja
    Sediva, Anna
    Horvath, Rudolf
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [45] Rehabilitation assisted by robotic and electromechanical devices for persons with neurological disabilities: an Italian consensus conference
    Boldrini, Paolo
    Bonaiuti, Donatella
    Mazzoleni, Stefano
    Posteraro, Federico
    [J]. FUNCTIONAL NEUROLOGY, 2019, 34 (02) : 123 - 124
  • [47] TRPM2 Cation Channels, Oxidative Stress and Neurological Diseases: Where Are We Now?
    Mustafa Nazıroğlu
    [J]. Neurochemical Research, 2011, 36 : 355 - 366
  • [48] TRPM2 Cation Channels, Oxidative Stress and Neurological Diseases: Where Are We Now?
    Naziroglu, Mustafa
    [J]. NEUROCHEMICAL RESEARCH, 2011, 36 (03) : 355 - 366
  • [49] Tailored Treatments in Temporomandibular Disorders: Where Are We Now? A Systematic Qualitative Literature Review
    Kotiranta, Ulla
    Suvinen, Tuija
    Forssell, Heli
    [J]. JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE, 2014, 28 (01) : 28 - 37
  • [50] In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?
    Lubroth, Pablo
    Colasante, Gaia
    Lignani, Gabriele
    [J]. FRONTIERS IN NEUROSCIENCE, 2021, 15